Delivering on the promise of early detection with liquid biopsies
Cet article passe en revue les progrès récents concernant l'utilisation des ARNs non codants comme biomarqueurs non invasifs en cancérologie, analyse l'intérêt de rechercher dans le sang certains types d'ARNs non codants puis examine l'impact des récentes avancées technologiques sur le développement de biomarqueurs moléculaires non invasifs
Liquid biopsy approaches are relatively well developed for cancer therapy monitoring and disease relapse, but they also have incredible potential in the cancer early detection and screening field. There are, however, several challenges to overcome before this potential can be met. Research in this area needs to be cohesive and, as a driver of research, Cancer Research UK is in an ideal position to enable this.
British Journal of Cancer , commentaire en libre accès, 2022